|
1
|
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.
|
Cancer Res
|
2012
|
2.23
|
|
2
|
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.
|
Cancer Res
|
2011
|
1.35
|
|
3
|
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.
|
Hum Pathol
|
2011
|
1.14
|
|
4
|
Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7).
|
J Biol Chem
|
2013
|
0.95
|
|
5
|
Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
|
Cancer
|
2014
|
0.90
|
|
6
|
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.
|
Med Oncol
|
2015
|
0.85
|
|
7
|
Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
|
Histopathology
|
2011
|
0.83
|
|
8
|
Prostate specific membrane antigen (PSMA): a novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells.
|
Prostate
|
2012
|
0.83
|
|
9
|
MUC1 glycopeptide epitopes predicted by computational glycomics.
|
Int J Oncol
|
2012
|
0.79
|
|
10
|
Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.
|
Med Oncol
|
2010
|
0.79
|
|
11
|
Composite lymphoma with relapse of enteropathy-type T-cell lymphoma.
|
Leuk Lymphoma
|
2009
|
0.78
|
|
12
|
Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells.
|
Med Oncol
|
2011
|
0.75
|
|
13
|
[Pathologic diagnosis and histogenesis of primary signet ring cell carcinoma of the prostate].
|
Zhonghua Bing Li Xue Za Zhi
|
2002
|
0.75
|